; and (ii) to assist in the education and training of health care providers, patients, and the general public regarding the risk reduction or prevention, symptoms, diagnosis, and treatment of congenital Cytomegalovirus, including, as necessary, through the publication of scientific, evidence-based educational materials on Internet webpages maintained by State agencies or designated entities of States. (B) Authorization of appropriations There is authorized to be appropriated to carry out subparagraph (A) such sums as may be necessary for each of fiscal years 2024 and 2025. (3) National Institutes of Health (A) In general The Director of the National Institutes of Health shall— (i) for the purposes of this section, establish a program, or expand existing programs, of research and development on the efficacy of new screening techniques and technology relating to congenital Cytomegalovirus, including clinical studies of screening methods, studies on efficacy of intervention, and related research; and (ii) establish a program, or expand existing programs, of research and development into congenital Cytomegalovirus diagnostics, prevention, treatments including public health awareness campaigns, risk reduction, and vaccine development, and cures or treatments (during pregnancy and after birth). (B) Funding The Director of the National Institutes of Health shall carry out subparagraph (A) using amounts available to the Director and not otherwise obligated. . 3. Advisory committee on heritable disorders in newborns and children Section 1111(b) of the Public Health Service Act ( 42 U.S.C. 300b–10(b) ) is amended— (1) in paragraph (7) by striking and after the semicolon; (2) by redesignating paragraph (8) as paragraph (9); and (3) by inserting after paragraph (7) the following: (8) carry out activities under section 1116A; and .